<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Publications ‚Äî Tiansheng (Tian) Wang</title>
  <meta name="description" content="Publications by Tiansheng (Tian) Wang ‚Äî Pharmacoepidemiology, causal inference, machine learning." />

  <!-- Fonts + Shared CSS -->
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700;800&display=swap" rel="stylesheet">
  <link rel="stylesheet" href="/assets/styles.css?v=11">

  <!-- Featured slider styles -->
  <style>
    .feature-hero{position:relative;border:1px solid var(--border);background:var(--card);
      border-radius:16px;padding:12px;overflow:hidden;max-width:100%}
    .feature-track{position:relative}
    .feature-slide{display:none !important;gap:16px;align-items:start}
    .feature-slide.active{display:grid !important;grid-template-columns:minmax(0,1.1fr) minmax(0,.9fr)}
    .feature-media{display:flex;align-items:center;justify-content:center}
    .feature-media img{width:100%;height:auto;max-height:55vh;object-fit:contain;border-radius:12px;border:1px solid var(--border);box-shadow:0 20px 60px rgba(0,0,0,.35)}
    .feature-title{margin:0 0 6px}
    .feature-caption{color:var(--muted);margin-top:6px}
    .feature-nav{position:absolute;top:50%;transform:translateY(-50%);width:44px;height:44px;border-radius:999px;border:1px solid var(--border);
      background:var(--card);color:var(--fg);display:flex;align-items:center;justify-content:center;cursor:pointer;box-shadow:0 8px 24px rgba(0,0,0,.25);z-index:10}
    .feature-nav.prev{left:10px}.feature-nav.next{right:10px}.feature-nav:hover{filter:brightness(1.05)}
    @media (max-width:900px){.feature-slide.active{grid-template-columns:1fr}.feature-media img{max-height:45vh}}

    /* Collapsible years */
    details.pub-year{border:1px solid var(--border);border-radius:12px;background:var(--card);padding:12px;margin:10px 0}
    details.pub-year summary{list-style:none;cursor:pointer;font-weight:700;display:flex;align-items:center;gap:8px}
    details.pub-year summary::before{content:"‚ñ∏";transition:transform .2s ease}
    details.pub-year[open] summary::before{transform:rotate(90deg)}
    details.pub-year ul{margin:12px 0 0 18px}
    .pub li{margin:8px 0}
  </style>

  <link rel="icon" href="/images/favicon.jpg" sizes="32x32">
  <link rel="icon" type="image/svg+xml" href="/images/favicon.svg">
</head>
<body>

<header>
  <div class="container">
    <nav>
      <div class="brand"><a href="/index.html">Tiansheng (Tian) Wang</a></div>
      <div class="nav">
        <a href="/index.html">Home</a>
        <a href="/lab.html">CausalRx.AI Lab</a>
        <a href="/software.html">Software</a>
        <a href="/publications.html" class="active">Publications</a>
        <a href="/gallery.html">Gallery</a>
        <button id="themeToggle" class="toggle" aria-label="Toggle light/dark">üåô</button>
      </div>
    </nav>
  </div>
</header>

<main>

<!-- Quick links -->
<section class="reveal" style="border-bottom:1px solid var(--border);">
  <div class="container">
    <h1 style="margin-bottom:8px;">Publications</h1>
    <p class="subtitle" style="margin-top:0;">Peer-reviewed articles and selected conference presentations.</p>

    <div style="display:flex;flex-wrap:wrap;gap:10px;margin-top:14px;">
      <a class="ghost" target="_blank" rel="noopener"
         href="https://pubmed.ncbi.nlm.nih.gov/?term=%28Tiansheng%20Wang%5BAuthor%5D%29%20AND%20%28%22Peking%20University%22%5BAffiliation%5D%20OR%20%22North%20Dakota%20State%20University%22%5BAffiliation%5D%20OR%20%22University%20of%20North%20Carolina%22%5BAffiliation%5D%20OR%20%22University%20of%20Houston%22%5BAffiliation%5D%29%20AND%20%282011%2F08%2F01%5BDate%20-%20Publication%5D%20%3A%203000%5BDate%20-%20Publication%5D%29">
        üîé PubMed (since 2011)
      </a>
      <a class="ghost" href="https://scholar.google.com/citations?user=JYtT5K8AAAAJ&hl=en" target="_blank" rel="noopener">
        G Google Scholar
      </a>
      <a class="ghost" href="https://orcid.org/0000-0002-0980-8896" target="_blank" rel="noopener">
        üÜî ORCID
      </a>
    </div>
  </div>
</section>

<!-- FEATURED slider (unchanged) -->
<section class="reveal">
  <div class="container">
    <h2 style="margin-bottom:14px;">Featured</h2>
    <div class="feature-hero" id="featureHero">
      <button class="feature-nav prev" aria-label="Previous">‚ü®</button>
      <div class="feature-track" id="featureTrack" aria-live="polite">
        <article class="feature-slide active" aria-hidden="false">
          <div class="feature-media">
            <img src="/images/figures/FIGURE1_all_Panels_AB.jpg" alt="iCF workflow">
          </div>
          <div class="feature-meta">
            <h3 class="feature-title">
              <a href="https://doi.org/10.1093/aje/kwad219" target="_blank" rel="noopener">
                Iterative Causal Forest: A Novel Algorithm for Subgroup Identification
              </a>
            </h3>
            <p class="subtitle"><em>American Journal of Epidemiology</em>, 2024</p>
            <p class="feature-caption">We've developed a machine learning subgrouping algorithm based on causal forest to better identify subpopulation who will benefit (or be harmed) more from a specific treatment. 
              The iCF algorithm iteratively develops shallow causal forests at different depths to obtain a family of subgroup decisions, then selects the cross-validated decision that best predicts causal treatment effect.</p>
          </div>
        </article>
        <article class="feature-slide" aria-hidden="true">
          <div class="feature-media">
            <img src="/images/figures/FIGURE1_hdiCF_3KEYsteps.jpg" alt="hdiCF steps">
          </div>
          <div class="feature-meta">
            <h3 class="feature-title">
              <a href="https://doi.org/10.1093/aje/kwae322" target="_blank" rel="noopener">
                High-dimensional Iterative Causal Forest (hdiCF)
              </a>
            </h3>
            <p class="subtitle"><em>American Journal of Epidemiology</em>, 2024</p>
            <p class="feature-caption">hdiCF extends iCF to high-dimensional claims data, using diagnosis/procedure/prescription codes to identify subgroups with heterogeneous treatment effects.</p>
          </div>
        </article>
        <article class="feature-slide" aria-hidden="true">
          <div class="feature-media">
            <img src="/images/figures/Fig3_StudyDesignTimeline_Dementia.jpg" alt="ADRD identification timeline">
          </div>
          <div class="feature-meta">
            <h3 class="feature-title">
              <a href="https://doi.org/10.1093/aje/kwaf166" target="_blank" rel="noopener">
                A Novel Algorithm to Identify Incident and Prevalent Dementia in Medicare Claims (ARIC)
              </a>
            </h3>
            <p class="subtitle"><em>American Journal of Epidemiology</em>, 2025</p>
            <p class="feature-caption">Using Medicare claims from ARIC participants and ARIC‚Äôs syndromic dementia classification, we developed and validated claims-based algorithms to identify incident and prevalent dementia.</p>
          </div>
        </article>
      </div>
      <button class="feature-nav next" aria-label="Next">‚ü©</button>
    </div>
    <p class="subtitle" style="margin-top:8px;color:var(--muted)">Tip: use ‚Üê / ‚Üí or swipe to navigate. Auto-plays and pauses on hover.</p>
  </div>
</section>

<!-- Full publications by year (collapsible) -->
<section class="reveal">
  <div class="container">
    <h2>Publications by Year</h2>

    <!-- 2025 -->
    <details class="pub-year" open>
      <summary>2025</summary>
      <ul class="pub">
        <li><strong>80.</strong> Guo J, <strong>Wang T</strong>, Liu Z, Zeng W, Shen P, Sun Y, Zhan S, Xu Y. Estimating Cardiovascular Effects of Influenza Vaccination in Older Adults: A Target Trial Emulation Using Proximal Causal Inference. <em>eClinicalMedicine</em>. 2025 <a href="https://doi.org/10.1016/j.eclinm.2025.103449" target="_blank" rel="noopener">https://doi.org/10.1111/dom.70002</a></li>
        <li><strong>79.</strong> Her QL, <strong>Wang T</strong>, St√ºrmer T, Buse JB, Jonsson-Funk M, Webster-Clark M. Suicidality among overweight and obese patients after semaglutide exposure in a United States commercial insurance population: a real-world study. <em>Diabetes Obes Metab</em>. 2025;1‚Äê10. <a href="https://doi.org/10.1111/dom.70002" target="_blank" rel="noopener">https://doi.org/10.1111/dom.70002</a></li>
        <li><strong>78.</strong> <strong>Wang T</strong>, Pate V, Kim DH, Power MC; Garden G, Palta P, Knopman D, Jonson-Funk M, St√ºrmer T, Kucharska-Newton AM. Developing A Novel Algorithm to Identify Incident and Prevalent Dementia in Medicare Claims for Pharmacoepidemiologic Studies. The ARIC Study. <em>Am J Epidemiol</em>. 2025 Aug 4:kwaf166. <a href="https://doi.org/10.1093/aje/kwaf166" target="_blank" rel="noopener">https://doi.org/10.1093/aje/kwaf166</a></li>
        <li><strong>77.</strong> <strong>Wang T*</strong>, Wang J, Kinlaw AC, Wyss R, Pate V, Gou Z, Buse JB, Keet CA, Kosorok MR, St√ºrmer T. Glucagon-like Peptide 1 Receptor Agonists in Asthma Exacerbations: an Application of High-dimensional Iterative Causal Forest to Identify Subgroups. <em>Pharmacoepidemiol Drug Saf</em>. 2025;34:e70192. <a href="https://doi.org/10.1002/pds.70192" target="_blank" rel="noopener">https://doi.org/10.1002/pds.70192</a></li>
        <li><strong>76.</strong> <strong>Wang T*</strong>, Pate V, Wyss R, Buse JB, Kosorok MR, St√ºrmer T. A Novel High Dimensional Approach to Assess Heterogeneous Treatment Effect in Claims Data. <em>Am J Epidemiol</em>. 2025. <a href="https://doi.org/10.1093/aje/kwaf127" target="_blank" rel="noopener">https://doi.org/10.1093/aje/kwaf127</a></li>
        <li><strong>75.</strong> Zeng W, <strong>Wang T</strong>, St√ºrmer T, He N, Shen P, Lin H, Guan X, Xu Y. Comparative effectiveness of ACE inhibitors and ARBs on cardiovascular outcomes in older adults with T2DM: a target trial emulation study. <em>Cardiovasc Diabetol</em>. 2025;24:194.</li>
        <li><strong>74.</strong> <strong>Wang T</strong>, Wang J, Song Z, Miller E, Pate V, Her Q, Yang J, Charlier SHR, Egger P, Barnes EL, Buse JB, Becker C, Sandler RS, Meier C, Jick S, St√ºrmer T. Caution in Handling Switchers in Pharmacoepidemiologic Studies Estimating Treatment Effects: The Example of DPP-4 Inhibitors and IBD. <em>Am J Epidemiol</em>. 2025. <a href="https://doi.org/10.1093/aje/kwaf044" target="_blank" rel="noopener">https://doi.org/10.1093/aje/kwaf044</a></li>
        <li><strong>73.</strong> Guo J, <strong>Wang T</strong>, Cao H, Ma Q, Tang Y, Li T, Wang L, Xu Y, Zhan S. Application of methodological strategies to address unmeasured confounding in real-world vaccine safety and effectiveness study: a systematic review. <em>J Clin Epidemiol</em>. 2025. <a href="https://www.jclinepi.com/article/S0895-4356(25)00070-8/abstract" target="_blank" rel="noopener">Journal page</a></li>
        <li><strong>72.</strong> Ji D, Dong S, <strong>Wang T</strong>, Wei J, Shen P, Lin H, Shi L, Guang X, Yang X. Statin Use and Risk of Intracerebral Hemorrhage in Chinese Population: A Target Trial Emulation Study. <em>Neurology</em>. 2025. <a href="https://www.neurology.org/doi/10.1212/WNL.0000000000213489" target="_blank" rel="noopener">Neurology</a></li>
      </ul>
    </details>

    <!-- 2024 -->
    <details class="pub-year">
      <summary>2024</summary>
      <ul class="pub">
        <li><strong>71.</strong> <strong>Wang T</strong>, Ji D, St√ºrmer T, Ismail S, Dong S, Shen P, Lin H, Shi L, Guan X, Xu Y. The Effect of SGLT2 Inhibitors on Hemoglobin A1C Variability and Acute Kidney Injury: A Causal Mediation Analysis. <em>Pharmacoepidemiol Drug Saf</em>. 2024 Aug;33(8):e5876. (Cover Image: <a href="https://onlinelibrary.wiley.com/doi/abs/10.1002/pds.70039" target="_blank" rel="noopener">link</a>)</li>
        <li><strong>70.</strong> <strong>Wang T*</strong>, Keil AP, Buse JB, Keet C, Kim S, Wyss R, Pate V, Jonsson-Funk M, Pratley RE, Kvist K, Kosorok MR, St√ºrmer T. GLP-1 Receptor Agonists and Asthma Exacerbations: Which Patients Benefit Most? <em>Ann Am Thorac Soc</em>. 2024 Jul 16. <a href="https://www.atsjournals.org/doi/abs/10.1513/AnnalsATS.202309-836OC" target="_blank" rel="noopener">journal</a></li>
        <li><strong>69.</strong> <strong>Wang T*</strong>, Pate V, Wyss R, Buse JB, Kosorok MR, St√ºrmer T. High-dimensional Iterative Causal Forest (hdiCF): a Novel Algorithm for Subgroup Identification in Claims Data. <em>Am J Epidemiol</em>. 2024 Sep 5;194(7):2085‚Äì97. <a href="https://doi.org/10.1093/aje/kwae322" target="_blank" rel="noopener">https://doi.org/10.1093/aje/kwae322</a></li>
        <li><strong>68.</strong> <strong>Wang T</strong>, Keil AP, Kim S, Wyss R, Htoo PT, Funk MJ, Buse JB, Kosorok MR, St√ºrmer T. Iterative Causal Forest: A Novel Algorithm for Subgroup Identification. <em>Am J Epidemiol</em>. 2024 May 7;193(5):764‚Äì776.</li>
        <li><strong>67.</strong> Her QL, Dejene SZ, Ismail S, <strong>Wang T</strong>, Jonsson-Funk M, Pate V, Min JY, Flory J. Validation of an ICD-10-CM algorithm in identifying severe hypoglycemia events in large health care databases. <em>Diabetes Obes Metab</em>. 2024 Apr;26(4):1282‚Äì1290.</li>
      </ul>
    </details>

    <!-- 2023 -->
    <details class="pub-year">
      <summary>2023</summary>
      <ul class="pub">
        <li><strong>66.</strong> Wei J, Xu H, Zhang D, Tang H, <strong>Wang T</strong>, Steck SE, Divers J, Zhang J, Merchant AT. Initiation of Antihypertensive Medication from Midlife on Incident Dementia: The Health and Retirement Study. <em>J Alzheimers Dis</em>. 2023 Jul 5. doi:10.3233/JAD-230398.</li>
        <li><strong>65.</strong> Wei J, Xu H, Liese A, Merchant A, Wang L, Yang CH, Lohman M, Brown M, <strong>Wang T</strong>, Friedman D. The 10-Year CVD Risk Score and Cognitive Function among Older Adults: NHANES 2011‚Äì2014. <em>J Am Heart Assoc</em>. 2023 Jun 6;12(11):e028527.</li>
        <li><strong>64.</strong> Li X, Zhou L, Gaggl M, Kinlaw AC, Gou Z, Yang X, Wei J, <strong>Wang T*</strong>. Remdesivir for COVID-19 and AKI: FAERS disproportionality analysis. <em>Int J Clin Pharm</em>. 2023 Apr;45(2):509‚Äì514.</li>
      </ul>
    </details>

    <!-- 2022 -->
    <details class="pub-year">
      <summary>2022</summary>
      <ul class="pub">
        <li><strong>63.</strong> Htoo PT, Buse JB, Cavender M, <strong>Wang T</strong>, Pate V, Edwards J, St√ºrmer T. Comparative cardiovascular effects of SGLT2i and GLP-1RA in older patients with diabetes across CV risk profiles: cohort study. <em>J Am Heart Assoc</em>. 2022 Feb 15;11(4):e022376.</li>
        <li><strong>62.</strong> Zhao Y, Zhang J, Zheng K, Thai S, Simpson RJ, Kinlaw AC, Xu Y, Wei J, Cui X, Buse JB, St√ºrmer T, <strong>Wang T*</strong>. Serious CV adverse events with hydroxychloroquine/chloroquine ¬± azithromycin in COVID-19: FAERS analysis. <em>Drugs - Real World Outcomes</em>. 2022 Jun;9(2):231‚Äì241.</li>
      </ul>
    </details>

    <!-- 2021 -->
    <details class="pub-year">
      <summary>2021</summary>
      <ul class="pub">
        <li><strong>61.</strong> Webster-Clark M, St√ºrmer T, <strong>Wang T</strong>, et al. Using propensity scores to estimate effects of treatment initiation decisions: State of the science. <em>Stat Med</em>. 2021 Mar 30;40(7):1718‚Äì1735.</li>
        <li><strong>60.</strong> Guo M, Thai S, Zhou J, Wei J, Zhao Y, Xu W, <strong>Wang T*</strong>, Cui X. Evaluation of DOAC-associated hemorrhagic events using FAERS. <em>Int J Clin Pharm</em>. 2021 Jun 9.</li>
        <li><strong>59.</strong> Tang H, Zhou L, Li X, Kinlaw AC, Yang JY, Moon AM, Barnes EL, <strong>Wang T</strong>. DILI with lopinavir-ritonavir in COVID-19: FAERS disproportionality. <em>Int J Clin Pharm</em>. 2021 Aug;43(4):1116‚Äì1122.</li>
        <li><strong>58.</strong> Wei J, Ali MK, <strong>Wang T</strong>, Xu H. Abdominal aortic calcification and cognitive function among older adults. <em>Int J Geriatr Psychiatry</em>. 2021 Nov;36(11):1778‚Äì1784.</li>
        <li><strong>57.</strong> Wei J, Hou R, Xie L, Chandrasekar EK, Lu H, <strong>Wang T</strong>, Li C, Xu H. Sleep, sedentary, physical activity, and cognitive function: NHANES 2011‚Äì2014. <em>J Sci Med Sport</em>. 2021 Feb;24(2):189‚Äì194.</li>
      </ul>
    </details>

    <!-- 2020 -->
    <details class="pub-year">
      <summary>2020</summary>
      <ul class="pub">
        <li><strong>56.</strong> St√ºrmer T, <strong>Wang T</strong>, Golightly YM, et al. Methodological considerations for real-world data. <em>Rheumatology</em>. 2020;59:1425.</li>
        <li><strong>55.</strong> Xu Y, <strong>Wang T</strong>, Yang Z, Lin H, Shen P, Zhan S. Sulfonylurea monotherapy and HF hospitalization risk in T2DM: China cohort. <em>PDS</em> 2020 Jun;29(6):635‚Äì643.</li>
        <li><strong>54.</strong> Yang JY, <strong>Wang T</strong>, Pate V, Buse JB, St√ºrmer T. SGLT2i and Fournier‚Äôs gangrene: real-world evidence. <em>BMJ Open Diabetes Res Care</em>. 2020;8:e000985.</li>
        <li><strong>53.</strong> Li D, Silvester JA, Crowley MJ, Yang JY, Alexopoulos AS, Xu Y, Zhan S, <strong>Wang T*</strong>. DPP-4 inhibitors use and celiac disease: FAERS analysis. <em>Ther Adv Chronic Dis</em>. 2020;11:1‚Äì3.</li>
        <li><strong>52.</strong> Lu W, Sun S, Wei J, Thai S, Li D, Tang H, <strong>Wang T</strong>, Sun L. DPP-4 inhibitors and VTE: FAERS data mining. <em>Int J Clin Pharm</em>. 2020 Oct;42(5):1364‚Äì1368.</li>
        <li><strong>51.</strong> Zhao M, Sun S, Huang Z, <strong>Wang T</strong>, Tang H. Network meta-analysis of novel glucose-lowering drugs on AKI risk. <em>CJASN</em>. 2020 Dec 31;16(1):70‚Äì78.</li>
        <li><strong>50.</strong> Xin L, Sun S, Wang J, Lu W, <strong>Wang T</strong>, Tang H. DPP-4 inhibitors and VTE risk: CV outcomes trials meta-analysis. <em>Thromb Haemost</em>. 2020.</li>
        <li><strong>49.</strong> Li D, Wu T, <strong>Wang T</strong>, et al. SGLT2i and dyslipidemia risk: RCT meta-analysis. <em>Pharmacoepidemiol Drug Saf</em>. 2020 May;29(5):582‚Äì590.</li>
      </ul>
    </details>

    <!-- 2019 -->
    <details class="pub-year">
      <summary>2019</summary>
      <ul class="pub">
        <li><strong>48.</strong> <strong>Wang T</strong>, Yang YJ, Buse JB, Pate V, Tang H, Barnes EL, Sandler RS, St√ºrmer T. DPP-4 inhibitors and IBD risk: US adults real-world evidence. <em>Diabetes Care</em>. 2019 Nov;42(11):2065‚Äì2074.</li>
        <li><strong>47.</strong> Yang JY, <strong>Wang T</strong>, et al. SGLT2i and lower-extremity amputation: evolving evidence. <em>Diabetes Obes Metab</em>. 2019 May;21(5):1223‚Äì1236.</li>
        <li><strong>46.</strong> <strong>Wang T*</strong>, Lu W, Tang H, Buse JB, St√ºrmer T, Gower EW. GLP-1RA and diabetic retinopathy: FAERS analysis. <em>Diabetes Care</em>. 2019 Feb;42(2):e21‚Äìe23.</li>
        <li><strong>45.</strong> <strong>Wang T*</strong>, Lu W, Li D, Yang JY, Tang H, Buse JB, St√ºrmer T. DPP-4 inhibitors and IBD: FAERS analysis. <em>Diabetes Care</em>. 2019 Jun;42(6):e89‚Äìe91.</li>
        <li><strong>44.</strong> Wei J, Xie L, Song S, <strong>Wang T</strong>, Li C. Isotemporal substitution of sedentary behavior with PA and depressive symptoms in older adults: NHANES 2007‚Äì2016. <em>J Affect Disord</em>. 2019 Jul 5;257:257‚Äì262.</li>
        <li><strong>43.</strong> Wei J, Ying M, Xie L, Chandrasekar EK, Lu H, <strong>Wang T</strong>, Li C. Late-life depression and cognitive function in older US adults: NHANES 2011‚Äì2014. <em>J Psychiatr Res</em>. 2019 Apr;111:30‚Äì35.</li>
        <li><strong>42.</strong> Li G, Crowley M, Tang H, Yang JY, Sander RS, <strong>Wang T*</strong>. DPP-4 inhibitors and IBD risk: RCT meta-analysis. <em>Diabetes Care</em>. 2019 Jul;42(7):e119‚Äìe121.</li>
        <li><strong>41.</strong> Wang A, Yang K, <strong>Wang T</strong>, et al. SGLT2i and VTE risk: systematic review and meta-analysis. <em>Diabetes Metab Res Rev</em>. 2019;e3174.</li>
      </ul>
    </details>

    <!-- 2018 -->
    <details class="pub-year">
      <summary>2018</summary>
      <ul class="pub">
        <li><strong>40.</strong> Wei J, Hou R, Kowalski A, <strong>Wang T</strong>, et al. ALA intake and CHD risk: dose-response meta-analysis. <em>Br J Nutr</em>. 2018 Jan;119(1):83‚Äì89.</li>
        <li><strong>39.</strong> <strong>Wang T</strong>, Hong J-L, Gower EW, Pate V, Garg S, Buse JB, St√ºrmer T. Incretin-based therapies and diabetic retinopathy: older US adults. <em>Diabetes Care</em>. 2018 Sep;41(9):1998‚Äì2009.</li>
        <li><strong>38.</strong> Li X, Thai S, Lu W, Sun S, Tang H, Zhai S, <strong>Wang T*</strong>. TCM and drug-induced anaphylaxis: Beijing pharmacovigilance database. <em>Int J Clin Pharm</em>. 2018 Aug;40(4):921‚Äì927.</li>
        <li><strong>37.</strong> Zhao Y, Lu H, Thai S, Li X, Tang H, Hui J, Zhai S, Sun L, <strong>Wang T*</strong>. Algorithm to identify drug-induced anaphylaxis: Beijing DB. <em>Int J Clin Pharm</em>. 2018 Aug;40(4):862‚Äì869.</li>
        <li><strong>36.</strong> Xing Y, Zhang H, Sun S, Ma X, Pleasants R, Tang H, Zheng H, Zhai S, <strong>Wang T*</strong>. Pediatric drug-induced anaphylaxis: features & treatment. <em>Eur J Pediatr</em>. 2018 Jan;177(1):145‚Äì154.</li>
        <li><strong>35.</strong> Zhao Y, Sun S, Li X, Ma X, Tang H, Sun L, Zhai S, <strong>Wang T*</strong>. Drug-induced anaphylaxis in China: 10-year analysis. <em>Int J Clin Pharm</em>. 2018 Oct;40(5):1349‚Äì1358.</li>
        <li><strong>34.</strong> Zhao Y, <strong>Wang T</strong>, Li G, Sun S. Pharmacovigilance in China: development and challenges. <em>Int J Clin Pharm</em>. 2018 Aug;40(4):823‚Äì831.</li>
        <li><strong>33.</strong> Tang H, Li G, Zhao Y, Wang F, Gower EW, Shi L, <strong>Wang T*</strong>. DR events across glucose-lowering drugs: network meta-analysis. <em>Diabetes Obes Metab</em>. 2018 May;20(5):1262‚Äì1279.</li>
        <li><strong>32.</strong> Li D, Shi W, <strong>Wang T</strong>, Tang H. SGLT2i + DPP-4i combo therapy: systematic review & meta-analysis. <em>Diabetes Obes Metab</em>. 2018 Aug;20(8):1972‚Äì1976.</li>
        <li><strong>31.</strong> Tang H, Shi W, Fu S, <strong>Wang T</strong>, Zhai S, Song Y, Han J. Pioglitazone and bladder cancer risk: systematic review & meta-analysis. <em>Cancer Med</em>. 2018 Apr;7(4):1070‚Äì1080.</li>
        <li><strong>30.</strong> Li D, Yang JY, <strong>Wang T</strong>, Shen S, Tang H. SGLT2i and diabetic foot / amputation risk: meta-analysis. <em>Diabetes & Metabolism</em>. 2018 Nov;44(5):410‚Äì414.</li>
        <li><strong>29.</strong> Pleasants RA, <strong>Wang T</strong>, Xu X, et al. Nebulized corticosteroids for COPD exacerbations: SR/MA & perspective. <em>Respir Care</em>. 2018 Oct;63(10):1302‚Äì1310.</li>
        <li><strong>28.</strong> Cui JY, Zhou RR, Han S, <strong>Wang T</strong>, et al. Statin therapy and glycemic control in T2D: network meta-analysis. <em>J Clin Pharm Ther</em>. 2018 Aug;43(4):556‚Äì570.</li>
        <li><strong>27.</strong> Wang X, Li M, Wang M, Cui S, Shi L, <strong>Wang T*</strong>. Mobile messaging-based case studies in pharmacotherapy class. <em>J Comput Assist Learn</em>. 2018;34:526‚Äì533.</li>
      </ul>
    </details>

    <!-- 2017 -->
    <details class="pub-year">
      <summary>2017</summary>
      <ul class="pub">
        <li><strong>26.</strong> <strong>Wang T</strong>, Ma X, Xing Y, Sun S, Zhang H, St√ºrmer T, et al. Epinephrine use in drug-induced anaphylaxis: Beijing DB. <em>Int Arch Allergy Immunol</em>. 2017;173(1):51‚Äì60.</li>
        <li><strong>25.</strong> Tang H, Li D, Zhang J, Li Y, <strong>Wang T</strong>, Zhai S, Song Y. SGLT2i and adverse renal outcomes: network & cumulative meta-analysis of RCTs. <em>Diabetes Obes Metab</em>. 2017 Aug;19(8):1106‚Äì1115.</li>
        <li><strong>24.</strong> Liu Y, Li J, <strong>Wang T</strong>, Wang Y, Zhao L, Fang Y. Genistein and glucose/insulin sensitivity in postmenopausal women: meta-analysis. <em>Maturitas</em>. 2017 Mar;97:44‚Äì52.</li>
        <li><strong>23.</strong> Li D, <strong>Wang T</strong>, Shen S, Fang Z, Dong Y, Tang H. UTI/genital infections with SGLT2i: RCT meta-analysis. <em>Diabetes Obes Metab</em>. 2017 Mar;19(3):348‚Äì355.</li>
        <li><strong>22.</strong> Tang H, Cui W, Li D, <strong>Wang T</strong>, Zhang J, Zhai S, Song Y. SGLT2i added to insulin for T2D: RCT meta-analysis. <em>Diabetes Obes Metab</em>. 2017 Jan;19(1):142‚Äì147.</li>
      </ul>
    </details>

    <!-- 2016 -->
    <details class="pub-year">
      <summary>2016</summary>
      <ul class="pub">
        <li><strong>21.</strong> Tang H, Li D, <strong>Wang T</strong>, Zhai S, Song Y. SGLT2i and DKA among T2D: RCT meta-analysis. <em>Diabetes Care</em>. 2016 Aug;39(8):e123‚Äì4.</li>
        <li><strong>20.</strong> Tang H, Li D, Zhang J, Hsu Y, <strong>Wang T</strong>, Zhai S, Song Y. SGLT2i and fracture risk: network & cumulative meta-analysis. <em>Diabetes Obes Metab</em>. 2016 Dec;18(12):1199‚Äì1206.</li>
        <li><strong>19.</strong> Liu F, Wang HM, <strong>Wang T</strong>, Zhang YM, Zhu X. Thymosin Œ±1 for sepsis: SR of RCTs. <em>BMC Infect Dis</em>. 2016 Sep 15;16:488.</li>
        <li><strong>18.</strong> Tang H, Fang Z, <strong>Wang T</strong>, Cui W, Zhai S, Song Y. SGLT2i on CV outcomes and all-cause mortality: meta-analysis. <em>Am J Cardiol</em>. 2016 Dec 1;118(11):1774‚Äì1780.</li>
        <li><strong>17.</strong> Li X, Yu C, <strong>Wang T</strong>, Tang H. CYP2C19 polymorphisms and voriconazole outcomes: SR/MA. <em>Eur J Clin Pharmacol</em>. 2016 Oct;72(10):1185‚Äì1193.</li>
        <li><strong>16.</strong> Zhou J, Ma X, <strong>Wang T</strong>, Zhai S. Bisphosphonates for short-term fracture prevention in primary osteoporosis: network MA. <em>Osteoporos Int</em>. 2016 Nov;27(11):3289‚Äì3300.</li>
        <li><strong>15.</strong> Li J, Liu Y, <strong>Wang T</strong>, Zhao L, Feng W. Genistein and plasma lipids/homocysteine in postmenopausal women: meta-analysis. <em>Climacteric</em>. 2016 Oct;19(5):440‚Äì447.</li>
        <li><strong>14.</strong> Zhou J, <strong>Wang T</strong>, Zhao X, Miller DR, Zhai S. Bisphosphonates to prevent fracture in men: SR with network MA. <em>Rheumatol Ther</em>. 2016 Jun;3(1):117‚Äì128.</li>
        <li><strong>13.</strong> <strong>Wang T</strong>, Wang F, Zhou J, Tang H, Giovenale S. CV & arrhythmia events with incretin therapies: meta-analysis of RCTs. <em>Diabetes Metab Res Rev</em>. 2016 Nov;32(8):843‚Äì857.</li>
        <li><strong>12.</strong> Jin H, <strong>Wang T*</strong>, Falcione B, et al. Voriconazole trough concentration vs efficacy/safety: SR/MA. <em>J Antimicrob Chemother</em>. 2016 Jul;71(7):1772‚Äì1785.</li>
        <li><strong>11.</strong> Pleasants R, <strong>Wang T</strong>, Gao J, Tang HL, Donohue J. Inhaled umeclidinium in COPD: SR/MA. <em>Drugs</em>. 2016 Mar;76(3):343‚Äì361.</li>
        <li><strong>10.</strong> <strong>Wang T</strong>, Wang F, Xin X, Pleasants R, Shi L. Using microblogs for health communication with a pharmacist-based account. <em>Patient Educ Couns</em>. 2016 Aug;99(8):1432‚Äì1437.</li>
      </ul>
    </details>

    <!-- 2015 -->
    <details class="pub-year">
      <summary>2015</summary>
      <ul class="pub">
        <li><strong>9.</strong> <strong>Wang T</strong>, Wang F, Gou Z, Tang H, Li C, Shi L, Zhai SD. Incretin-based therapies & acute pancreatitis risk: meta-analysis of 1,324,515 pts from observational studies. <em>Diabetes Obes Metab</em>. 2015 Jan;17(1):32‚Äì41.</li>
        <li><strong>8.</strong> <strong>Wang T</strong>, Benedict N, Olsen KM, et al. Critical care pharmacist‚Äôs interventions & medication errors: SR/MA of observational studies. <em>J Crit Care</em>. 2015 Oct;30(5):1101‚Äì1108.</li>
        <li><strong>7.</strong> Li D, <strong>Wang T</strong>, Shen S, Yu J, Zhang Y, Zhang C, Tang H. Fluoroquinolones in newly diagnosed, sputum-positive TB therapy: SR & network MA. <em>PLoS ONE</em>. 2015 Dec 15;10(12):e0145066.</li>
        <li><strong>6.</strong> Tang HL, Yan YY, <strong>Wang T</strong>, et al. FSHR Asn680Ser polymorphism and controlled ovarian hyperstimulation outcomes: updated meta-analysis. <em>J Assist Reprod Genet</em>. 2015 Dec;32(12):1801‚Äì1810.</li>
      </ul>
    </details>

    <!-- 2014 -->
    <details class="pub-year">
      <summary>2014</summary>
      <ul class="pub">
        <li><strong>5.</strong> <strong>Wang T</strong>, Gou Z, Wang F, Ma M, Zhai SD. GLP-1 analogues vs sitagliptin in T2D: head-to-head SR/MA. <em>PLoS ONE</em>. 2014 Aug 4;9(8):e103798.</li>
      </ul>
    </details>

    <!-- 2013 -->
    <details class="pub-year">
      <summary>2013</summary>
      <ul class="pub">
        <li><strong>4.</strong> <strong>Wang T</strong>, Wang F, Shi L. Microblog-based case studies in a pharmacotherapy intro class in China. <em>BMC Med Educ</em>. 2013 Sep 8;13:120.</li>
      </ul>
    </details>

    <!-- 2012 -->
    <details class="pub-year">
      <summary>2012</summary>
      <ul class="pub">
        <li><strong>3.</strong> Yi ZM, Zhai SD, Huang S, <strong>Wang T</strong>, Liu F. Off-label prescriptions for adult neurological patients: pilot survey in China. <em>Int J Clin Pharm</em>. 2012 Feb;34(1):81‚Äì87.</li>
        <li><strong>2.</strong> Natesan S, <strong>Wang T</strong>, Lukacova V, et al. Cell-QSAR: dissection of receptor binding & intracellular disposition in antifilarial activities of Selwood antimycins. <em>J Med Chem</em>. 2012 Apr 26;55(8):3699‚Äì3712.</li>
      </ul>
    </details>

    <!-- 2011 -->
    <details class="pub-year">
      <summary>2011</summary>
      <ul class="pub">
        <li><strong>1.</strong> Natesan S, <strong>Wang T</strong>, Lukacova V, Bartus V, Khandelwal A, Balaz S. Multispecies multimode ligand-receptor interactions in 3D-QSAR: CoMFA of thyroxine analogs binding to transthyretin. <em>J Chem Inf Model</em>. 2011;51(5):1132‚Äì1150.</li>
      </ul>
    </details>

  </div>
</section>
</main>

<section id="contact" class="reveal">
  <div class="container">
    <h2>Contact</h2>
    <p><strong>Email:</strong> <a href="mailto:tianwang@uh.edu">tianwang@uh.edu</a> ¬∑ <strong>GitHub:</strong> <a href="https://github.com/tianshengwang" target="_blank">@tianshengwang</a></p>
    <p style="color:#7c869a">¬© <span id="year"></span> Tiansheng (Tian) Wang ‚Äî Built with vanilla HTML/CSS, animated blobs, and scroll-reveal ‚ú¶ Hosted on GitHub Pages.</p>
  </div>
</section>

<button id="toTop" class="toTop" aria-label="Back to top">‚Üë</button>

<!-- Shared + slider JS -->
<script defer src="/assets/site.js"></script>
<script>
  // Featured slider (unchanged)
  (() => {
    const hero = document.getElementById('featureHero');
    if (!hero) return;
    const slides = Array.from(hero.querySelectorAll('.feature-slide'));
    if (!slides.length) return;
    let i = 0;
    const prev = hero.querySelector('.feature-nav.prev');
    const next = hero.querySelector('.feature-nav.next');

    const setActive = (idx) => {
      slides.forEach((s, k) => {
        const on = (k === idx);
        s.classList.toggle('active', on);
        s.setAttribute('aria-hidden', on ? 'false' : 'true');
      });
    };

    const goPrev = () => { i = (i - 1 + slides.length) % slides.length; setActive(i); };
    const goNext = () => { i = (i + 1) % slides.length; setActive(i); };

    prev?.addEventListener('click', goPrev);
    next?.addEventListener('click', goNext);

    // Keyboard
    document.addEventListener('keydown', (e)=>{
      if (e.key === 'ArrowLeft') goPrev();
      else if (e.key === 'ArrowRight') goNext();
    });

    // Swipe
    let startX = null;
    hero.addEventListener('touchstart', (e)=>{ startX = e.touches[0].clientX; }, {passive:true});
    hero.addEventListener('touchend', (e)=>{
      if (startX === null) return;
      const dx = e.changedTouches[0].clientX - startX;
      if (Math.abs(dx) > 40) { dx > 0 ? goPrev() : goNext(); }
      startX = null;
    }, {passive:true});

    // Auto-play with pause on hover & visibility
    let timer = null;
    const intervalMs = 6000;
    const start = () => { stop(); timer = setInterval(goNext, intervalMs); };
    const stop  = () => { if (timer) { clearInterval(timer); timer = null; } };

    hero.addEventListener('mouseenter', stop);
    hero.addEventListener('mouseleave', start);
    document.addEventListener('visibilitychange', () => { document.hidden ? stop() : start(); });

    setActive(0);
    start();
  })();
</script>
</body>
</html>

